2-4-diaminopteridine and Edema

Reactive oxygen species are associated with inflammation implicated in cancer, atherosclerosis and autoimmune diseases. The complex nature of inflammation and of oxidative stress suggests that dual-target agents may be effective in combating diseases involving reactive oxygen species.. A novel series of N-substituted 2,4-diaminopteridines has been synthesized and evaluated as antioxidants in several assays. Many exhibited potent lipid antioxidant properties, and some are inhibitors of soybean lipoxygenase, IC50 values extending down to 100 nM for both targets. Several pteridine derivatives showed efficacy at 0.01 mmol/kg with little tissue damage in a rat model of colitis. 2-(4-methylpiperazin-1-yl)-N-(thiophen-2-ylmethyl)pteridin-4-amine (18f) at 0.01 mmol/kg exhibited potent anti-inflammatory activity (reduction by 41%).. The 2,4-diaminopteridine core represents a new scaffold for lipoxygenase inhibition as well as sustaining anti-inflammatory properties.

Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Colitis; Diamines; Disease Models, Animal; Edema; Free Radical Scavengers; Glycine max; Lipoxygenase; Lipoxygenase Inhibitors; Male; Molecular Docking Simulation; Protein Binding; Protein Structure, Tertiary; Pteridines; Rats; Reactive Oxygen Species